Stocks · Healthcare · Medical - Healthcare Information Services
Privia Health Group, Inc. PRVA
$20.30 +1.35% Close, Oct 2, 2026 · NASDAQ · Market cap $2.56B
Inexpensive vs sectorLow risk
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $0.22, up 87.5% year over year.
- The shares trade at 93.6× trailing earnings, lower than 93% of the company's own readings over the past five years.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 29%
- EPS growth (TTM, YoY)Top 15%
- FCF growth (TTM, YoY)Bottom 10%
- Revenue growth, 3-year CAGRTop 37%
- Revenue growth accelerationBottom 45%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 32%
- Gross marginBottom 9%
- Operating marginTop 40%
- Cash conversion (OCF / net income)Bottom 1%
- Accruals (lower is better)Bottom 18%
- Net debt / EBITDA (lower is better)Top 1%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 27%
- Free-cash-flow yieldTop 42%
- P/E vs own 5-year history (lower is better)Top 20%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 25%
- 6-month returnBottom 38%
- 1-year return vs S&P 500Bottom 30%
- Distance from 52-week highTop 46%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 36%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 26%
- Upside to consensus price targetBottom 37%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 7%
- Maximum drawdown, 3 yearsTop 7%
- Beta vs S&P 500 (lower is better)Top 28%
- Net debt / EBITDA (lower is better)Top 1%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 24.7% | 24.1% | ↓ |
| EPS growth (YoY) | 34.5% | 87.5% | ↑ |
| Gross margin | 9.8% | 7.6% | ↓ |
| Operating margin | 1.0% | 1.9% | ↑ |
| FCF margin | 4.8% | -2.0% | ↓ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 24.1% | 24.7% | ↓ | Top 29% |
| EPS growth (TTM, YoY) | 87.5% | 34.5% | ↑ | Top 15% |
| Gross margin | 7.6% | 9.8% | ↓ | Bottom 9% |
| Operating margin | 1.9% | 1.0% | ↑ | Top 40% |
| Net margin | 1.2% | 0.8% | ↑ | — |
| Free-cash-flow margin | -2.0% | 4.8% | ↓ | — |
| Return on invested capital | 0.0% | — | Top 32% | |
| Revenue growth, 3-year CAGR | 16.1% | — | Top 37% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- -1.67×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 0.0%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 1752.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +129193.0 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- -5918.89×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.15%
- Shareholder yield
- -0.15%
- Share count change, 1 year
- +2.6%
- Share count change, 3-year CAGR
- +1.9%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -3.2%
- Average 2-day reaction, last 8
- +2.0%
- Positive 20 days after report
- 2 of 8
Analysts
- Consensus price target
- $27.33
- Target vs current price
- +34.6%
- Analysts with a rating
- 22
- Share rating Buy or Strong Buy
- 91%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | +3.9% | -8.2% | -10.1% | -13.5% | — |
| May 7, 2026 | -75.0% | +0.0% | -5.7% | -10.9% | -0.8% |
| Feb 26, 2026 | +75.0% | +10.0% | +7.3% | -9.3% | -0.0% |
| Nov 6, 2025 | -16.7% | -4.2% | -3.2% | -4.1% | -10.3% |
| Aug 7, 2025 | -60.0% | -1.4% | +6.3% | +16.9% | +23.9% |
| May 8, 2025 | -50.0% | +7.5% | +4.2% | -2.2% | -16.5% |
| Feb 27, 2025 | -40.0% | +5.8% | +6.8% | -4.9% | -4.0% |
| Nov 7, 2024 | -40.0% | +6.5% | +3.2% | +0.3% | +10.5% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | $0.07 | $0.07 | +3.9% | $632.6M |
| May 7, 2026 | $0.02 | $0.08 | -75.0% | $603.8M |
| Feb 26, 2026 | $0.07 | $0.04 | +75.0% | $541.2M |
| Nov 6, 2025 | $0.05 | $0.06 | -16.7% | $580.4M |
| Aug 7, 2025 | $0.02 | $0.05 | -60.0% | $521.2M |
| May 8, 2025 | $0.03 | $0.06 | -50.0% | $480.1M |
| Feb 27, 2025 | $0.03 | $0.05 | -40.0% | $460.9M |
| Nov 7, 2024 | $0.03 | $0.05 | -40.0% | $437.9M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 93.6× | 152.1× | 7th | Top 27% |
| P/E (forward) | 78.8× | — | — | — |
| Free-cash-flow yield | -1.89% | — | — | Top 42% |
| Earnings yield | 1.07% | — | — | Top 27% |
P/E over the past five years
Range 75.9× – 253.8× since Mar 31, 2023. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
What moved the stock over the past year
- Price return, 1 year
- -18.7%
- Earnings per share growth (TTM)
- +87.5%
- Change in P/E multiple
- -39.9%
Most of the move came from earnings growth.
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -11.1%
- 200-day average slope (20 days)
- -1.7%
- Distance from 50-day average
- -4.9%
- Distance from 200-day average
- -11.2%
- RSI (14)
- 48.5
- Relative volume
- 0.96×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 27.9%
- Volatility vs own 5-year history
- 1th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.71
- Correlation with S&P 500
- 0.33
- Current drawdown from 1-year high
- -27.8%
- Maximum drawdown, 3 years
- -33.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jun 28, 2021 | May 20, 2024 | -67.3% | 728 days | Not yet recovered |
| May 5, 2021 | May 14, 2021 | -23.3% | 7 days | 17 days (Jun 9, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.56B
- P/E (TTM)
- 93.6
- EPS, diluted (TTM)
- $0.22
- Revenue (TTM)
- $2.36B
- 52-week range
- $18.92 – $28.82
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $966.2M | $1.36B | $1.66B | $1.74B | $2.12B |
| Gross profit | $63.7M | $134.8M | $161.5M | $176.9M | $209.4M |
| Operating income | -$217.4M | -$19.1M | $20.6M | $17.0M | $34.2M |
| Net income | -$188.2M | -$8.6M | $23.1M | $14.4M | $22.9M |
| EPS (diluted) | -$1.77 | -$0.08 | $0.19 | $0.11 | $0.18 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $437.9M | $460.9M | $480.1M | $521.2M | $580.4M | $541.2M | $603.8M | $632.6M |
| Net income | $3.5M | $4.4M | $4.2M | $2.7M | $6.9M | $9.2M | $3.1M | $9.0M |
| EPS (diluted) | $0.03 | $0.03 | $0.03 | $0.02 | $0.05 | $0.07 | $0.02 | $0.07 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $55.1M | $47.2M | $80.8M | $109.3M | $163.4M |
| Capital expenditure | -$547,000 | -$104,000 | -$113,000 | -$5.0M | -$1.2M |
| Free cash flow | $54.5M | $47.1M | $80.7M | $104.3M | $162.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $223.7M | $13.4M | $8.7M | $2.7M | $8.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $412.20B
- Total assets
- $1.49T
- Total liabilities
- $650.51B
- Total debt
- $8.73B
- Net debt
- -$403.47B
- Shareholders’ equity
- $782.33B
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 4,900,411
- Days to cover
- 3.96
- Change vs previous report
- -10.2%
FINRA short interest, settlement date Sep 15, 2026.